52 in 52 – #42: The “FABLED” Trial
52 in 52 looks at blood culture sensitivity after administration of antibiotics in the FABLED trial.
52 in 52 – #42: The “FABLED” Trial Read More »
52 in 52 – #40: DIRECT MT – Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
The 52 in 52 series covers the DIRECT MT trial: thrombectomy alone or thrombectomy plus alteplase for LVO within 4.5 hours of symptom onset.
52 in 52 – #35: ECASIII Reanalysis
This week we cover “Thrombolysis with alteplase 3–4.5 hours after acute ischemic stroke: trial reanalysis adjusted for baseline imbalances”, a reanalysis of ECASIII and tPA for stroke.
52 in 52 – #35: ECASIII Reanalysis Read More »
52 in 52 – #34: Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke (EXTEND-IA TNK)
This week we cover the EXTEND-IA TNK study, which evaluates TNK versus tPA before thrombectomy.
52 in 52 – #33: The PREVENT Trial
52 in 52 covers the PREVENT trial for this week’s article. Does low (6 mL/kg) tidal volume reduce ventilator free days in ventilated patients without ARDS compared to intermediate tidal volume (10 mL/kg)?
52 in 52 – #33: The PREVENT Trial Read More »
52 in 52 – #32: Hydrocortisone in Severe Community-Acquired Pneumonia
This week the ’52 in 52′ series covers hydrocortisone in patients with severe community-acquired pneumonia, or the CAPE-COD trial.
52 in 52 – #32: Hydrocortisone in Severe Community-Acquired Pneumonia Read More »
52 in 52 – #31: Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence Induction of Anesthesia
This week the 52 in 52 series looks at cricoid pressure in RSI.
52 in 52 – #30: Sensitivity of modern multi-slice CT for subarachnoid hemorrhage at incremental timepoints after headache onset
52 in 52 looks at sensitivity of multi-slice CT for subarachnoid hemorrhage at different timepoints from symptom onset.
52 in 52 – #25: Association of Rivaroxaban vs. Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
The 52 in 52 series returns with #25,w which looks at risk of major ischemic or hemorrhagic event with rivaroxaban versus apixaban.
52 in 52 – #24: Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation
The 52 in 52 series looks at angiography after out-of-hospital cardiac arrest without ST elevation in the TOMAHAWK Trial.